Author

J. Erasmus

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Organism:rat· 2 Research Focus:benchmarking· 1 Approach:deep learning· 1 Organism:human· 1

Frequent Co-Authors

A. P. Khandhar· 3 shared D. H. Fuller· 3 shared D. W. Hawman· 2 shared H. Feldmann· 2 shared J. Archer· 2 shared K. Meade-White· 2 shared M. Gale· 2 shared P. Berglund· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. P. Khandhar

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Protein design for evaluating vaccines against future viral variation

N. Youssef, S. Gurev, F. Ghantous, K. P. Brock, J. A. Jaimes, N. N. Thadani, A. Dauphin, A. C. Sherman, L. Yurkovetskiy, D. Soto, R. Estanboulieh, B. Kotzen, P. Notin, A. W. Kollasch, A. A. Cohen, , D. Marks

The paper designs SARS-CoV-2 Spike proteins with novel mutations to evaluate vaccine effectiveness against future viral variants using a deep learning model.

bioRxiv · Oct 8, 2023Immunology

Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine

Z. MacMillen, K. Hatzakis, A. Simpson, M. J. Shears, F. Watson, J. Erasmus, A. P. Khandhar, B. K. Wilder, S. C. Murphy, S. G. Reed, J. W. Davie, M. Avril

This paper develops an accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine that provides sterile protection with a single day regimen.

bioRxiv · May 23, 2023Immunology

Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine

D. W. Hawman, K. Meade-White, C. Clancy, J. Archer, T. Hinkley, S. Leventhal, D. Rao, A. Stamper, M. Lewis, R. Rosenke, K. Krieger, S. Randall, A. P. Khandhar, L. Hao, T.-Y. Hsiang, , J. Erasmus

bioRxiv · Jan 31, 2022Microbiology

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern

D. W. Hawman, K. Meade-White, J. Archer, S. Leventhal, D. Wilson, C. Shaia, S. Randall, A. P. Khandhar, T.-Y. Hsiang, M. Gale, P. Berglund, D. H. Fuller, H. Feldmann, J. Erasmus

This study evaluates a replicating RNA vaccine against SARS-CoV-2 variants, showing protection from disease and reduced viral shedding after heterologous challenge.

bioRxiv · Dec 10, 2021Microbiology